Press Releases

INDIANAPOLIS, Oct. 11, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) has approved REYVOW™ (lasmiditan) an oral medication for the acute treatment of migraine, with or without aura, in adults. REYVOW has a unique mechanism of action and is the first and only FDA-approved medicine in a new clas

MINNEAPOLIS, Oct. 11, 2019 /PRNewswire/ -- Minneapolis-based health insurance marketplace and benefits partner, Gravie, is announcing an individual coverage health reimburse

OAKLAND, Calif., Oct. 11, 2019 /PRNewswire/ -- Kaiser Permanente is again among the nation's best for providing safe and effective care and exceptional service to its Medicare members. According to the

BALTIMORE, Oct. 11, 2019 /PRNewswire/ -- The African American Neuroscience Research Initiative (AANRI) announced today the receipt of a $275,000 grant from the Abell Foundation, which will provide critical funds to support the development and growth of the collaboration between the African American Clergy Medical Research Initiative and the

SILVER SPRING, Md., Oct. 11, 2019 /PRNewswire/ -- The U.S. Food and Drug Administration today approved Reyvow (lasmiditan) tablets for the acute (active but short-term) treatment of migraine with or without aura (a sensory phenomenon or visual disturbance) in adults. Reyvow is not indicated for the preventive treatment of migraine.

NEW YORK, Oct. 11, 2019 /PRNewswire/ -- Spherix Incorporated (Nasdaq: SPEX) today announced that on October 2, 2019, the Board of Directors of Spherix Incorporated ("Spherix") approved a distribution to Spherix stockholders of 100,000 shares of Hoth Therapeutics, Inc. ("Hoth") held by Spherix.

WOBURN, Mass., Oct. 11, 2019 /PRNewswire/ -- Agrivida, a privately held biotechnology company, today announces the appointment of board member Rajiv Singh as interim CEO with the departure of current CEO Dan Meagher. Meagher has accepted an executive position with a global animal health and nutrition company,

DANA POINT, Calif., Oct. 11, 2019 /PRNewswire/ -- A recent report from the California Department of Health reported alarming news about the opioid crisis, specifically fatal overdoses from the synthetic opioid drug, fentanyl. In the past 4 years, fentanyl overdose deaths have skyrocketed 614% in California, alone. Fentanyl is the most pot

CHICAGO, Oct. 11, 2019 /PRNewswire/ -- Specialdocs Consultants, a pioneer in concierge medicine transitions and ongoing management, announces two key appointments to its executive team: Dave Farr as vice president of business development and Shirin Zarinkia as vice president of strategy.

CHICAGO, Oct. 11, 2019 /PRNewswire/ -- Combined Insurance, a leading provider of voluntary supplemental accident, disability, health and life insurance products, and a Chubb company, has made two new senior leadership appointments. Nancy Goodwin has been appointed Senior Vice President, Chief Underwriting Officer. Al